Clinical Trial Update: Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the Norditropin NordiFlex device versus the device previously used by patients or their parents; the study is completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Fetal Growth Restriction
• Growth Hormone Deficiency
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children | Phase 4 | Status: COMPLETED | Results posted: 2012-06-25